- /
- Supported exchanges /
- PINK /
- CALA.PINK
Calithera Biosciences Inc (CALA PINK) stock market data APIs
Calithera Biosciences Inc Financial Data Overview
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Calithera Biosciences Inc data using free add-ons & libraries
Get Calithera Biosciences Inc Fundamental Data
Calithera Biosciences Inc Fundamental data includes:
- Net Revenue: 0
- EBITDA: -41 819 000
- Earnings Per Share: -7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-05-08
- EPS/Forecast: -3.03
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Calithera Biosciences Inc News
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
SOUTH SAN FRANCISCO, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: “CALA”). Calithera Biosciences, Inc. (the “Company”) announced that it was unable to achieve ...
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
SOUTH SAN FRANCISCO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (OTC: CALA) (the “Company”) announced that it intends to hold a special meeting of stockholders on or ab...
Calithera Biosciences Announces Update on Complete Liquidation and Dissolution
Calithera Biosciences, Inc. Special Meeting to be Held on or about June 29, 2023 with a Record Date of May 25, 2023 SOUTH SAN FRANCISCO, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Calithera Bioscience...
Biotech company Calithera plans its own death. Will others follow?
The Peninsula company's plan to close by the end of the first quarter is atypical in a biotech industry where executives try to keep their companies alive to the next milestone in order to raise more money. Continue reading
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.